BPC 157 is a synthetic, stable pentadecapeptide (sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro Ala-Asp-Asp-Ala-Gly-Leu-Val) originally derived from a protective protein found in human gastric juice

animal studies suggest it may support healing of gastric ulcers and damaged intestinal lining Preclinical models suggest it may help modulate inflammation, though this has not been established in controlled human trials Known risks and side effects: Because it is sold as an unregulated research chemical rather than a manufactured pharmaceutical, product purity and dosing accuracy cannot be verified, and the FDA has flagged potential impurities and manufacturing-quality concerns FDA's Category 2 determination specifically cited potential immune reactions and hypersensitivity as a safety concern User-reported (non-clinical-trial) effects include injection-site irritation, redness, or swelling, along with occasional headache, nausea, or lightheadedness, based on anecdotal reporting rather than controlled studies No long-term human safety data exists

Monthly IV therapy ensures you receive essential vitamins and nutrients directly into your bloodstream, optimizing absorption and enhancing overall health
It also supports the manufacture of creatine, an energy substrate for muscles